Covered recipient · General Payments record
MANDEEP SINGH UPPAL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$810.71
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $259.84 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $131.11 | 12 |
| Bayer HealthCare Pharmaceuticals Inc. | $36.29 | 2 |
| GlaxoSmithKline, LLC. | $28.91 | 2 |
| Amgen Inc. | $28.77 | 1 |
| Acerta Pharma LLC | $20.46 | 1 |
| Novo Nordisk AS | $14.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $28.77 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117706572 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.46 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105574372 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.38 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086357594 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $18.91 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086329972 | CMS |
| GlaxoSmithKline, LLC. | $13.83 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116613272 | CMS |
| GlaxoSmithKline, LLC. | $15.08 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116622557 | CMS |
| Lilly USA, LLC | $14.47 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135803354 | CMS |
| Lilly USA, LLC | $7.66 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135754703 | CMS |
| Lilly USA, LLC | $18.93 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135809609 | CMS |
| Lilly USA, LLC | $12.71 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135772405 | CMS |
| Lilly USA, LLC | $7.09 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135801848 | CMS |
| Lilly USA, LLC | $9.32 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135809607 | CMS |
| Lilly USA, LLC | $13.07 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135801850 | CMS |
| Lilly USA, LLC | $11.49 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135754705 | CMS |
| Lilly USA, LLC | $10.35 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135801852 | CMS |
| Lilly USA, LLC | $7.14 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135772407 | CMS |
| Lilly USA, LLC | $11.83 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135801854 | CMS |
| Lilly USA, LLC | $7.05 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135809611 | CMS |
| Novo Nordisk Inc | $14.30 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100370067 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.